Radiosensitization of human tumor cells by the phosphatidylinositol 3- kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA- dependent protein kinase and prolonged G2-M delay

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1149-1156

  Rosenzweig, Kenneth E ^a   Youmell, Matthew B ^a   Palayoor, Sanjewani T ^a   Price, Brendan D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; WORTMANNIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; DRUG EFFECT; ENZYME INHIBITION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CELL CYCLE; CELL LINE; CELL SURVIVAL; CHROMONES; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; G2 PHASE; HELA CELLS; HUMANS; MITOSIS; MORPHOLINES; NUCLEAR PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; RADIATION-SENSITIZING AGENTS; SIROLIMUS; TUMOR CELLS, CULTURED; X-RAYS;

EID: 0030814125     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Keith. C. T., and Schreiber, S. L. PIK-related kinases: DNA repair, recombination and cell cycle checkpoints. Science (Washington, DC), 270: 50-51, 1995.
2. Hunter, T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell, 83: 1-4, 1995.
3. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. A single Ataxia Telangiectasia gene with a product similar to PI3 kinase. Science (Washington DC), 268: 1749-1753, 1995.
4. Savitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F. S., Shiloh, Y., and Rotman, G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4: 2025-2032, 1995.
5. Hartley, K. O., Gell, D., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxis telangiectasia gene product. Cell, 82: 849-856, 1995.
6. Greenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obermaeir, B. and Petes, T. D. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell, 82: 823-829, 1995.
7. Morrow, D. M., Tagle, D. A., Shiloh, Y., Collins, F. S. and Hieter, P. TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell. 82: 831-840, 1995.
8. Paulovich, A. G., and Hartwell, L. H. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell, 82: 841-847, 1995.
9. Jimenez, G., Yucel, J., Rowley, R., and Subramani, S. The rad3+ gene of Schizosacchromyces pombe is involved in multiple checkpoint functions and in DNA repair. Proc. Natl. Acad. Sci. USA, 89: 4952-4956, 1992.
10. Hari, K. L., Santerre, A., Sckelsky, J. J., McKim, K. S., Boyd, J. B., and Hawley, R. S. The mei41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell, 82: 815-821, 1995.
11. McKinnon, P. Ataxia-telangiectasia: an inherited disorder of ionizing radiation sensitivity in man. Hum. Genet., 75: 197-208, 1987.
12. Meyn, M. S. Ataxia telangiectasia and cellular responses to DNA damage. Cancer Res., 55: 5991-6001, 1995.
13. Pandita, T. K., Pathak, S., and Geard, C. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet. Cell Genet., 71: 86-93, 1995.
14. Beamish, H., and Lavin, M. F. Radiosensitivity in ataxia telangiectasia: anomalies in radiation induced cell cycle delay. Int. J. Radiat. Biol., 65: 175-184, 1994.
15. Beamish, H., Khanna, K. K., and Lavin, M. F. Ionizing radiation and cell cycle progression in ataxia telangiectasia. Radiat. Res., 138: 130-133, 1994.
16. 2/M delay and cellular radiosensitivity. Int. J. Radiat. Biol., 66: 373-379, 1994.
17. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint utilizing p53 and gadd45 is defective in Ataxia Telangiectasia. Cell, 71: 587-597, 1992.
18. Duchaud, E., Ridet, A., Stoppa-Lyonnet, D., Janin, N., Moustacchi, E., and Rosseli, F. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res., 56: 1400-1401, 1996.
19. Biedermann, K., Sun, J., Giaccia, A. J., Tosto, L. M., and Brown, J. M. Scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in double strand break repair. Proc. Natl. Acad. Sci., USA, 88: 1394-1397, 1991.
20. Jackson, S. P., and Jeggo, P. A. DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. Trends Biochem. Sci., 20: 412-415, 1995.
21. Kirchgessner, C. U., Patil, C. K., Evans, J. W., Cuomo, C. A., Fried, L. M., Carter, T., Oettinger, M. A., and Brown, J. M. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science (Washington DC), 267: 1178-1183, 1995.
22. Hiles, I. D., Otsu, M., Volonia, S., Fry, M. J., Gout, I., Dhand, R., Panayotou, G., Ruiz-Larrea, F., Thompson, A., Totty, N. F., Hsuan, J. J., Courtneidge, S. A., Parker, P. J., and Waterfield, M. D. Phosphatidylinositol 3-kinase: structure and expression of the 110kd catalytic subunit. Cell, 70: 419-429, 1992.
23. Taccioli, G. E., Gottleib, T. M., Blunt, T., Priestly, A., Demengot, J., Mizuta, R., Lehman, A. R., Alt, F. W., Jackson, S. P., and Jeggo, P. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science (Washington DC), 265: 1442-1445, 1994.
24. Gottleib, T. M., and Jackson, S. P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell, 72: 131-142, 1993.
25. Lees-Miller, S. P., Godbout, R., Chan, D. W., Weifeid, M., Day, R. S., Barron, G. M., and Allalunis-Turner, J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive cell line. Science (Washington DC), 267: 1183-1185, 1995.
26. 2-terminal threonine residues. J. Biol. Chem., 264: 17275-17280, 1989.
27. Jung, M., Kondratyev, A., Lee, S. A., Dimtchev, A., and Dritschilo, A. ATM gene product phosphorylates iκB-α. Cancer Res., 57: 24-29, 1997.
28. Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W. F., Dodge, J., Grindley, G., and Vlahos, C. J. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res., 54: 2419-2423, 1994.
29. Nakanishi, S., Kakita, S., Takahashi, I., Kawahara, K., Tsukuda, E., Sano, T., Yamada, K., Yoshida, M., Kase, H., Matsuda, Y., Hashimoto, Y., and Nonomura, Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem., 267: 2157-2163, 1992.
30. Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., and Panayotou, G. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys802, a residue involved in the phosphate transfer reaction. Mol. Cell Biol., 16: 1722-1733, 1996.
31. Price, B. D., and Youmell, M. The PI 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res., 56: 246-250, 1996.
32. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
33. 1-arresting rapamycin receptor complex. Nature (Lond.), 369: 756-758, 1994.
34. Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., and Schreiber, S. L. Control of p70 S6 kinase activity by FRAP in vivo. Nature (Lond). 377: 441-446, 1995.
35. Tishler, R. B., Geard, C. R., Hall, E. J., and Schiff, P. B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res., 52: 3495-3498, 1992.
36. 1 checkpoint. Clin. Cancer Res., 2: 269-276, 1996.
37. Finnie, N. J., Gottleib, T. M., Blunt, T., Jeggo, P. A., and Jackson, S. P. DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc. Natl. Acad. Sci. USA, 92: 320-324, 1995.
38. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., and Anderson, C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell Biol., 12: 5041-5049, 1992.
39. Yao, R. Y., and Cooper, G. M. Requirement for phosphatidyl-3 kinase in the prevention of apoptosis by nerve growth factor. Science (Washington DC), 267: 2003-2006, 1995.
40. Kimura, K., Hattori, S., Kabuyama, Y., Shizawa, Y., Takayanagi, J., Nakamura, S., Toki, S., Matsuda, Y., Onodera, K., and Fukui, Y. Neurtie outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem., 269: 18961-18967, 1994.
41. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., and Ui, M. Blockage of chemotactic peptide induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem., 269: 3563-3567, 1994.
42. Allalunis-Turner, M. J., Lintott, L. G., Barron, G. M., Day, R. S., and Less-Miller, S. P. Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity. Cancer Res., 55: 5200-5202, 1995.
43. Gu, X-Y., Bennett, R. A. O., and Povirk, L. F. End-joining of free radical mediated DNA double-strand breaks in vitro is blocked by the kinase inhibitor wortmannin at a step preceding removal of damaged 3′ termini. J. Biol. Chem., 277: 19660-19663, 1996.
44. Hallahan, D. E., Virudachalam, S., Scwartz, J. L., Panje, N., Mustafi, R., and Weichselbaum, R. R. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat. Res., 129: 345-350, 1992.